DENTSPLY SIRONA stock weighs Q2 beat against 4.1% sales drop

DENTSPLY SIRONA stock was trading at USD 9.90 on Nasdaq on September 23, 2026 at 2:26 p.m. ET, down 0.46 percent from the previous close of USD 9.95. The dental technology company is balancing a quarterly earnings beat against a 4.1 percent year-over-year revenue decline.

Adjusted EPS beats consensus

In Q2 2026, adjusted earnings per share reached USD 0.52, exceeding the Zacks consensus estimate of USD 0.36 by 44.4 percent, according to Yahoo Finance. Revenue came in at USD 898 million, which was 1.6 percent above the consensus estimate, although reported sales declined 4.1 percent from the prior year.

The comparison matters because the earnings improvement did not yet translate into top-line growth. Constant-currency revenue fell 6.3 percent in Q2 2026, putting greater importance on cost control and the companys ability to convert dental technology investments into renewed demand.

Guidance holds at USD 1.40

DENTSPLY SIRONA maintained its 2026 outlook at USD 3.5 billion to USD 3.6 billion in net sales and adjusted EPS of USD 1.40 to USD 1.50, per Yahoo Finance. The range gives investors a concrete test for the recovery story: earnings must improve while sales stabilize.

MarketBeat reported on September 23, 2026 that Bank of America acquired 2,921,845 shares during Q2, worth USD 31,001,000 and equal to a 1.47 percent stake. The same report put the analyst consensus at Hold, with 3 Buy ratings, 9 Holds, 3 Sells and an average target price of USD 13.31.

Stock remains near yearly low

The USD 9.90 Nasdaq price on September 23, 2026 sits above the 52-week low of USD 9.36 and below the 52-week high of USD 14.76. DENTSPLY SIRONA had a market capitalization of USD 1,984,115,599 at the same market snapshot, leaving the Q2 earnings beat and the 4.1 percent sales decline as the central valuation signals.